Table 4.
Comparison of ANA and antibodies between ITP patients in the IVIg group and those in the non-IVIg group.
| IVIg group n (%) |
non-IVIg group n (%) |
t/Fisher’s | P value | |
|---|---|---|---|---|
| age(year) | 3.26 ± 4.13 | 4.01 ± 3.91 | -0.885 | 0.377 |
| Female | 10(37.04%) | 45(38.79%) | – | >0.9999 |
| PLT(×109/L) | 9.85 ± 7.50 | 10.34 ± 7.13 | -0.315 | 0.753 |
| IVIg+glucocorticoids | 9 | 21 | – | 0.113 |
| ANA | 13(48.15%) | 13(12.21%) | – | <0.0001 |
| speckled pattern | 10(37.04%) | 10(8.62%) | – | 0.0006 |
| cytoplasm particle pattern | 7(25.93%) | 3(2.59%) | – | 0.0003 |
| anti-SSA | 11(40.74%) | 1(0.86%) | – | <0.0001 |
| anti-Ro52 | 22(81.48%) | 2(1.72%) | – | <0.0001 |
| anti AMA-Mi2 | 14 (51.85%) | 0(0.0%) | – | <0.0001 |
Data are means ± standard deviation. Bold statistical significance.